View Single Post
Old 11-16-2015, 02:42 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,142
Will immunotherapy add value to chemotherapy for HER-2 positive gastric cancer?

The prognosis for patients with gastric cancer is poor. In western countries even patients with localized gastric or gastro-esophageal junction adenocarcinoma are faced with 5-year survival rates of...

More...
News is offline   Reply With Quote